These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 16128233)

  • 1. Co-effect of aqueous solubility of drugs and glycolide monomer on in vitro release rates from poly(D,L-lactide-co-glycolide) discs and polymer degradation.
    Kim JM; Seo KS; Jeong YK; Hai BL; Kim YS; Khang G
    J Biomater Sci Polym Ed; 2005; 16(8):991-1007. PubMed ID: 16128233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lactide/glycolide monomers on release behaviors of gentamicin sulfate-loaded PLGA discs.
    Yoo JY; Kim JM; Khang G; Kim MS; Cho SH; Lee HB; Kim YS
    Int J Pharm; 2004 May; 276(1-2):1-9. PubMed ID: 15113609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation behaviour in vitro for poly(D,L-lactide-co-glycolide) as drug carrier.
    Lee JS; Chae GS; Kim MS; Cho SH; Lee HB; Khang G
    Biomed Mater Eng; 2004; 14(2):185-92. PubMed ID: 15156109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states.
    Kranz H; Ubrich N; Maincent P; Bodmeier R
    J Pharm Sci; 2000 Dec; 89(12):1558-66. PubMed ID: 11042603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin release from poly(D,L-lactide) and poly(lactide-co-glycolide) disks.
    Ozalp Y; Ozdemir N; Hasirci V
    J Microencapsul; 2002; 19(1):83-94. PubMed ID: 11811762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetracycline-HCl-loaded poly(DL-lactide-co-glycolide) microspheres prepared by a spray drying technique: influence of gamma-irradiation on radical formation and polymer degradation.
    Bittner B; Mäder K; Kroll C; Borchert HH; Kissel T
    J Control Release; 1999 May; 59(1):23-32. PubMed ID: 10210719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained release of mitomycin-C from poly(DL-lactide) /poly(DL-lactide-co-glycolide) films.
    Gümüşderelioglu M; Deniz G
    J Biomater Sci Polym Ed; 2000; 11(10):1039-50. PubMed ID: 11211156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
    Li X; Xu Y; Chen G; Wei P; Ping Q
    Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF.
    Pettit DK; Lawter JR; Huang WJ; Pankey SC; Nightlinger NS; Lynch DH; Schuh JA; Morrissey PJ; Gombotz WR
    Pharm Res; 1997 Oct; 14(10):1422-30. PubMed ID: 9358556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles.
    Panyam J; Dali MM; Sahoo SK; Ma W; Chakravarthi SS; Amidon GL; Levy RJ; Labhasetwar V
    J Control Release; 2003 Sep; 92(1-2):173-87. PubMed ID: 14499195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
    Kwon YM; Kim SW
    Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
    Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
    J Control Release; 1999 Aug; 60(2-3):279-86. PubMed ID: 10425333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
    Desai KG; Mallery SR; Schwendeman SP
    Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated polymer biodegradation of risperidone poly(D, L-lactide-co-glycolide) microspheres.
    Selmin F; Blasi P; DeLuca PP
    AAPS PharmSciTech; 2012 Dec; 13(4):1465-72. PubMed ID: 23090111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication and Use of Poly(d,l-lactide-co-glycolide)-Based Formulations Designed for Modified Release of 5-Fluorouracil.
    Leelakanok N; Geary S; Salem A
    J Pharm Sci; 2018 Feb; 107(2):513-528. PubMed ID: 29045885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
    Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
    Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained release microspheres of metoclopramide using poly(D,L-lactide-co-glycolide) copolymers.
    Elkheshen SA; Radwan MA
    J Microencapsul; 2000; 17(4):425-35. PubMed ID: 10898083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of divalent cations on pore formation and degradation of poly(D,L-lactide-co-glycolide).
    Fredenberg S; Reslow M; Axelsson A
    Pharm Dev Technol; 2007; 12(6):563-72. PubMed ID: 18161629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
    Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor Efficacy and Toxicity of 5-Fluorouracil-Loaded Poly(Lactide Co-glycolide) Pellets.
    Leelakanok N; Geary SM; Salem AK
    J Pharm Sci; 2018 Feb; 107(2):690-697. PubMed ID: 29031952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.